doi: 10.2337/ds16-0026 39 MaselliDBCamilleriM
i,j , the residual error of study i with j time
Both Tirzepatide and Semaglutide are effective in managing type 2 diabetes, they differ in their mechanisms of action, with tirzepatide incorporating the dual action of both GLP-1 and GIP to provide greater benefits for glycemic control and weight management
Given the limited efficacy of current anti-fibrotic therapies and the substantial morbidity associated with progressive pulmonary fibrosis, identification of novel pathways capable of modulating fibroblast activation and ECM remodelling remains a major therapeutic priority
What if these agents are psychiatric drugs that are masquerading as weight-loss drugs? Roger McIntyre More research is needed to confirm any potential connection between GLP-1 agonists and mental health, but several trials are ongoing
Behavioral Shifts: Helping patients recognize head hunger versus physiological hunger